Fellowship · Aurora, CO
Sponsored by University of Colorado School of Medicine
The Menopause Transition: Signs, Symptoms, and Management Options.
The Journal of clinical endocrinology and metabolism · 2021 · 411 citations · Nanette Santoro, Cassandra Roeca
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.
Lancet (London, England) · 2023 · 196 citations · Nanette Santoro
Menopause-Biology, consequences, supportive care, and therapeutic options.
Cell · 2023 · 159 citations · Nanette Santoro
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT.
The Journal of clinical endocrinology and metabolism · 2023 · 148 citations · Nanette Santoro
Body composition and cardiometabolic health across the menopause transition.
Obesity (Silver Spring, Md.) · 2022 · 166 citations · Nanette Santoro
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial.
Obstetrics and gynecology · 2023 · 95 citations ·
Infertility Evaluation and Treatment.
The New England journal of medicine · 2025 · 30 citations · Nanette Santoro, Alex Polotsky
Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos.
mSystems · 2022 · 105 citations · Nanette Santoro